This paper argues that current LLMs operate in a state structurally analogous to hyperdopaminergic psychosis, producing hallucination, delusion reinforcement, and pressured speech as reward-optimal behavior. We present dual evidence: LLM interactions amplify psychosis in schizophrenia-spectrum users and provide compensatory benefits for ADHD users—a pharmacological symmetry identical to amphetamine effects. We propose multi-neurotransmitter regulatory architectures as an urgent safety solution.
Batuhan Sadiç (Sun,) studied this question.